DNA damage repair in ovarian cancer: unlocking the heterogeneity

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Advanced ovarian cancer frequently relapses with resistant disease, necessitating novel therapeutic strategies.
• Defects in the DNA damage response (DDR) are a common characteristic of high-grade serous ovarian cancer (HGSOC).
• All HGSOCs exhibit deficiencies in at least one major DDR pathway, though mechanisms vary.

Purpose of the Study:

• To review the current understanding of DDR in ovarian cancer, specifically HGSOC.
• To explore how abrogations in DDR pathways can inform patient stratification.
• To discuss the implications for existing and emerging ovarian cancer treatments.

Main Methods:

• Literature review of DNA damage response pathways in ovarian cancer.
• Analysis of genetic and epigenetic lesions affecting DNA repair in HGSOC.
• Synthesis of current knowledge on DDR defects and therapeutic strategies.

Main Results:

• HGSOC is characterized by diverse (epi)genetic lesions impacting multiple DNA repair pathways.
• Understanding the interplay between DDR pathways is essential for effective treatment selection.
• Defective DDR provides a potential basis for stratifying patients for targeted therapies.

Conclusions:

• Targeting DDR pathways offers promise for improving outcomes in advanced ovarian cancer.
• Patient selection based on DDR status is key to optimizing treatment efficacy.
• Further research into DDR mechanisms will facilitate the development of novel therapeutic approaches for HGSOC.